6506-59-8 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 16 carbon (C) atoms, 11 hydrogen (H) atoms, and 5 nitrogen (N) atoms.
2. Bicyclic Heterocyclic Compound
Explanation
1,2,4-Triazolo[4,3-c]quinazoline, 5-phenyl- is composed of two fused rings, which are part of a larger class of compounds known as heterocyclic compounds. These are organic compounds containing one or more rings, with at least one heteroatom (atoms other than carbon) in the ring.
3. Triazoloquinazoline Ring System
Explanation
The core structure of 1,2,4-Triazolo[4,3-c]quinazoline, 5-phenyl- is a fused ring system consisting of a triazole (a five-membered ring with three nitrogen atoms) and a quinazoline (a fused six-membered and five-membered ring system with one nitrogen atom).
Explanation
The compound has potential applications in the field of medicinal chemistry, which involves the design, synthesis, and development of chemical compounds that can be used as drugs to treat various diseases and conditions.
6. Targeting Biological Pathways
Explanation
The compound may be used to target specific biological pathways, which are a series of molecular interactions that occur within a cell or organism. By targeting these pathways, the compound could potentially modulate or inhibit specific cellular processes, leading to therapeutic effects.
Explanation
The specific properties and potential uses of 1,2,4-Triazolo[4,3-c]quinazoline, 5-phenylare still being researched. This means that scientists are actively studying the compound to better understand its characteristics, potential applications, and any possible side effects or limitations.
Explanation
The compound may have promising applications in the field of drug discovery and development, which involves identifying and creating new drugs to treat various diseases and conditions. The compound's unique structure and potential to target specific biological pathways make it an interesting candidate for further research and development.
Phenyl Group Attachment
5-position
Potential Applications
Medicinal Chemistry
Ongoing Research
Specific Properties and Uses
Promising Applications
Drug Discovery and Development
Check Digit Verification of cas no
The CAS Registry Mumber 6506-59-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,5,0 and 6 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 6506-59:
(6*6)+(5*5)+(4*0)+(3*6)+(2*5)+(1*9)=98
98 % 10 = 8
So 6506-59-8 is a valid CAS Registry Number.
6506-59-8Relevant academic research and scientific papers
Synthesis and anticonvulsant activity evaluation of 5-Phenyl-[1,2,4] triazolo[4,3-c]quinazolin-3-amines
Zheng, Yan,Bian, Ming,Deng, Xian-Qing,Wang, Shi-Ben,Quan, Zhe-Shan
, p. 119 - 126 (2013/03/29)
In the present study we describe the syntheses and anticonvulsant activity evaluation of 5-phenyl-[1,2,4]triazolo[4,3-c]quinazolin-3-amine derivatives. Their anticonvulsant activity and neurotoxicity were evaluated by the maximal electroshock seizure test (MES) and the rotarod test, respectively. The majority of the compounds prepared were effective in the MES screens at a dose level of 100 mg/kg. Of these compounds, the most promising was compound 8h, which showed an ED50 value of 27.4 mg/kg and a protective index (PI) value of 5.8. These values were superior to those provided by valproate (ED50 and PI values of 272 and 1.6, respectively) in the MES test in mice. As well as its anti-MES efficacy, the potencies of compound 8h against seizures induced by pentylenetetrazole and thiosemicarbazide were also established, with the results suggesting that the GABAergic system-mediated mechanisms might be involved in its anticonvulsant activity. Copyright
Quinazoline Derivatives from 2-Phenyl-4-quinazolinylhydrazine
El-Sherief, Hassan Ahmed,Mahmoud, Abdalla Mohamed,Esmaiel, Ahmed Ahmed
, p. 1138 - 1142 (2007/10/02)
Formic acid and acetyl and benzoyl chloride were treated with 2-phenyl-4-quinazolinylhydrazine (1) under mild conditions to afford the corresponding hydrazides which were converted into 5-phenyltriazoloquinazoline, 2-methyl-5-phenyltr
